Evidence map›Paper›PMID 34151224›Full record

ArticleiScience2021

Categorization of lung mesenchymal cells in development and fibrosis.

Xue Liu, Simon C Rowan, Jiurong Liang, Changfu Yao, Guanling Huang, Nan Deng, Ting Xie, Di Wu, Yizhou Wang, Ankita Burman and 10 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genetic Strategies for Labeling AT2 Cells in Murine Lung via Abca3 and Etv5-Driven Reporters.Journal of respiratory biology and translational medicine · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Stromal heterogeneity in the adult lung delineated by single-cell genomics.American journal of physiology. Cell physiology · 2025
    Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 2 countries.

Xue LiuDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Simon C RowanDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Jiurong LiangDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Changfu YaoDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Guanling HuangDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Nan DengGenomics Core, Cedars-Sinai Medical Center, CA 90048, USA.
Ting XieDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Di WuGenomics Core, Cedars-Sinai Medical Center, CA 90048, USA.
Yizhou WangGenomics Core, Cedars-Sinai Medical Center, CA 90048, USA.
Ankita BurmanDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Tanyalak ParimonDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Zea BorokDivision of Pulmonary and Critical Care Medicine, Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, USA.
Peter ChenDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
William C ParksDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Cory M HogaboamDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
S Samuel WeigtDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
John BelperioDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Barry R StrippDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Paul W NobleDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Dianhua JiangDepartment of Medicine and Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Cedars-Sinai Medical Center · USUniversity of California, Los Angeles · USUniversity College Dublin · IEUniversity of Southern California · US

Funding

Role of Surfactant Proteins in Mediating Noninfectious Inflammatory and FibroproP01HL108793 · NHLBI · DUKE UNIVERSITY · PI STRIPP, BARRY R · 2012 to 2022
$21.3M
Beyond the Barrier: Alveolar Epithelial Cell Biology in Health and DiseaseR35HL135747 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOROK, ZEA · 2017 to 2023
$6.8M
MECHANISMS OF MACROPHAGE ACTIVATION IN LUNG INFLAMMATIONR01HL060539 · NHLBI · YALE UNIVERSITY · PI NOBLE, PAUL WESLEY · 1997 to 2019
$6.5M
Innate Immune Mechanisms of Non-infectious Lung InflammationR01AI052201 · NIAID · YALE UNIVERSITY · PI NOBLE, PAUL WESLEY · 2002 to 2021
$6.4M
Molecular Regulation of Progressive Pulmonary FibrosisR35HL150829 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Paul Wesley Noble · 2020 to 2026
$5.7M
Regulation of Pulmonary Fibrosis by CXCR3R01HL077291 · NHLBI · YALE UNIVERSITY · PI NOBLE, PAUL WESLEY · 2005 to 2013
$3.1M
Targeting beta-arrestins in Pulmonary FibrosisR01HL122068 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI JIANG, DIANHUA, NOBLE, PAUL WESLEY · 2015 to 2018
$2.1M
Innate DNA sensing in rapidly progressing IPFR01HL123899 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI HOGABOAM, CORY M · 2015 to 2018
$2.0M
Syndecan-1 regulation of lung fibrosisK08HL141590 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI PARIMON, TANYALAK · 2020 to 2024
$854k
Novel agents for idiopathic pulmonary fibrosisR43HL150986 · NHLBI · EPIGEN BIOSCIENCES, INC. · PI HOGABOAM, CORY M, TUCCI, FABIO COHEN · 2020 to 2020
$300k
NHLBI NIH HHS K08 HL141590NHLBI NIH HHS P01 HL108793NHLBI NIH HHS R01 HL060539NHLBI NIH HHS R01 HL077291NHLBI NIH HHS R01 HL122068NHLBI NIH HHS R01 HL123899NHLBI NIH HHS R35 HL135747NHLBI NIH HHS R35 HL150829NIAID NIH HHS R01 AI052201
6 · The paper itself

Abstract

Pulmonary mesenchymal cells are critical players in both the mouse and human during lung development and disease states. They are increasingly recognized as highly heterogeneous, but there is no consensus on subpopulations or discriminative markers for each subtype. We completed scRNA-seq analysis of mesenchymal cells from the embryonic, postnatal, adult and aged fibrotic lungs of mice and humans. We consistently identified and delineated the transcriptome of lipofibroblasts, myofibroblasts, smooth muscle cells, pericytes, mesothelial cells, and a novel population characterized by

Indexed as

cell biologyorganizational aspects of cell biologypathophysiology

Identifiers

PMID34151224
PMCPMC8188567
OpenAlexW3163736782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.